BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 31678916)

  • 1. A 22q13.33 duplication harbouring the SHANK3 gene: does it cause neuropsychiatric disorders?
    Johannessen M; Haugen IB; Bakken TL; Braaten Ø
    BMJ Case Rep; 2019 Nov; 12(11):. PubMed ID: 31678916
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lithium as a rescue therapy for regression and catatonia features in two SHANK3 patients with autism spectrum disorder: case reports.
    Serret S; Thümmler S; Dor E; Vesperini S; Santos A; Askenazy F
    BMC Psychiatry; 2015 May; 15():107. PubMed ID: 25947967
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 22q13.33 duplication involving SHANK3 gene: a boy and his mother with "persistent" language and speech sound disorder.
    Granocchio E; Pollina E; De Salvatore M; Scopelliti MR; Tanzi G; Sciacca FL; D'Arrigo S; Ciaccio C
    Psychiatr Genet; 2024 Feb; 34(1):19-23. PubMed ID: 38084626
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Brazilian cohort of individuals with Phelan-McDermid syndrome: genotype-phenotype correlation and identification of an atypical case.
    Samogy-Costa CI; Varella-Branco E; Monfardini F; Ferraz H; Fock RA; Barbosa RHA; Pessoa ALS; Perez ABA; Lourenço N; Vibranovski M; Krepischi A; Rosenberg C; Passos-Bueno MR
    J Neurodev Disord; 2019 Jul; 11(1):13. PubMed ID: 31319798
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical and molecular characterization of three genomic rearrangements at chromosome 22q13.3 associated with autism spectrum disorder.
    Chen CH; Chen HI; Liao HM; Chen YJ; Fang JS; Lee KF; Gau SS
    Psychiatr Genet; 2017 Feb; 27(1):23-33. PubMed ID: 27846046
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phelan-McDermid syndrome due to
    Egger JIM; Verhoeven WMA; Groenendijk-Reijenga R; Kant SG
    BMJ Case Rep; 2017 Sep; 2017():. PubMed ID: 28963116
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 22q13 deletion syndrome: communication disorder or autism? Evidence from a specific clinical and neurophysiological phenotype.
    Ponson L; Gomot M; Blanc R; Barthelemy C; Roux S; Munnich A; Romana S; Aguillon-Hernandez N; Malan V; Bonnet-Brilhault F
    Transl Psychiatry; 2018 Aug; 8(1):146. PubMed ID: 30089781
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A patient with the classic features of Phelan-McDermid syndrome and a high immunoglobulin E level caused by a cryptic interstitial 0.72-Mb deletion in the 22q13.2 region.
    Simenson K; Õiglane-Shlik E; Teek R; Kuuse K; Õunap K
    Am J Med Genet A; 2014 Mar; 164A(3):806-9. PubMed ID: 24375995
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Clinical phenotypes and genetic study of 2 cases with 22q13 deletion syndrome].
    Luo J; Fang D; Qiu W; Xiao B; Fan Y; Ye J; Han L; Zhang H; Yu Y; Liang L; Gu X
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2018 Jun; 35(3):361-365. PubMed ID: 29896732
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cerebellar and posterior fossa malformations in patients with autism-associated chromosome 22q13 terminal deletion.
    Aldinger KA; Kogan J; Kimonis V; Fernandez B; Horn D; Klopocki E; Chung B; Toutain A; Weksberg R; Millen KJ; Barkovich AJ; Dobyns WB
    Am J Med Genet A; 2013 Jan; 161A(1):131-6. PubMed ID: 23225497
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Advance of research on Phelan-McDermid syndrome].
    Li S; Xi K; Liu T; Zhang Y; Li J
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2021 Sep; 38(9):917-920. PubMed ID: 34487544
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neurocognitive follow-up in adult siblings with Phelan-McDermid syndrome due to a novel SHANK3 splicing site mutation.
    Kankuri-Tammilehto M; Sauna-Aho O; Arvio M
    Mol Genet Genomic Med; 2021 Dec; 9(12):e1780. PubMed ID: 34369668
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Microdeletion/duplication at 15q13.2q13.3 among individuals with features of autism and other neuropsychiatric disorders.
    Miller DT; Shen Y; Weiss LA; Korn J; Anselm I; Bridgemohan C; Cox GF; Dickinson H; Gentile J; Harris DJ; Hegde V; Hundley R; Khwaja O; Kothare S; Luedke C; Nasir R; Poduri A; Prasad K; Raffalli P; Reinhard A; Smith SE; Sobeih MM; Soul JS; Stoler J; Takeoka M; Tan WH; Thakuria J; Wolff R; Yusupov R; Gusella JF; Daly MJ; Wu BL
    J Med Genet; 2009 Apr; 46(4):242-8. PubMed ID: 18805830
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High proportion of 22q13 deletions and SHANK3 mutations in Chinese patients with intellectual disability.
    Gong X; Jiang YW; Zhang X; An Y; Zhang J; Wu Y; Wang J; Sun Y; Liu Y; Gao X; Shen Y; Wu X; Qiu Z; Jin L; Wu BL; Wang H
    PLoS One; 2012; 7(4):e34739. PubMed ID: 22509352
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A previously unrecognized 22q13.2 microdeletion syndrome that encompasses TCF20 and TNFRSF13C.
    Upadia J; Gonzales PR; Atkinson TP; Schroeder HW; Robin NH; Rudy NL; Mikhail FM
    Am J Med Genet A; 2018 Dec; 176(12):2791-2797. PubMed ID: 30216695
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Copy number variation analysis in adults with catatonia confirms haploinsufficiency of SHANK3 as a predisposing factor.
    Breckpot J; Vercruyssen M; Weyts E; Vandevoort S; D'Haenens G; Van Buggenhout G; Leempoels L; Brischoux-Boucher E; Van Maldergem L; Renieri A; Mencarelli MA; D'Angelo C; Mericq V; Hoffer MJ; Tauber M; Molinas C; Castiglioni C; Brison N; Vermeesch JR; Danckaerts M; Sienaert P; Devriendt K; Vogels A
    Eur J Med Genet; 2016 Sep; 59(9):436-43. PubMed ID: 27519580
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phelan McDermid Syndrome: Multiple Sclerosis as a Rare but Treatable Cause for Regression-A Case Report.
    Jesse S; Delling JP; Schön M; Boeckers TM; Ludolph A; Senel M
    Int J Mol Sci; 2021 Feb; 22(5):. PubMed ID: 33669083
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterisation of the clinical phenotype in Phelan-McDermid syndrome.
    Burdeus-Olavarrieta M; San José-Cáceres A; García-Alcón A; González-Peñas J; Hernández-Jusdado P; Parellada-Redondo M
    J Neurodev Disord; 2021 Jul; 13(1):26. PubMed ID: 34246244
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SHANK3 overexpression causes manic-like behaviour with unique pharmacogenetic properties.
    Han K; Holder JL; Schaaf CP; Lu H; Chen H; Kang H; Tang J; Wu Z; Hao S; Cheung SW; Yu P; Sun H; Breman AM; Patel A; Lu HC; Zoghbi HY
    Nature; 2013 Nov; 503(7474):72-7. PubMed ID: 24153177
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The spectrum of epilepsy and electroencephalographic abnormalities due to SHANK3 loss-of-function mutations.
    Holder JL; Quach MM
    Epilepsia; 2016 Oct; 57(10):1651-1659. PubMed ID: 27554343
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.